Divisas / CERO
CERO: CERo Therapeutics Holdings Inc
8.72
USD
0.13
(1.47%)
El tipo de cambio de CERO de hoy ha cambiado un -1.47%. En este caso, el precio mínimo en el mercado ha alcanzado 8.50, mientras que el máximo ha alcanzado 8.92.
Siga la dinámica de la pareja de divisas CERo Therapeutics Holdings Inc. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CERO News
- Investing Cero Therapeutics regains Nasdaq compliance after bid price deficiency
- Investing Cero Therapeutics adds institutional investors in Series D preferred stock sale
- Investing Cero Therapeutics stock rating upgraded to Buy on solid tumor approach
- Investing U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.10%
- Benzinga Dow Surges 150 Points; Korn Ferry Earnings Top Views - CERo Therapeutics Hldgs (NASDAQ:CERO), Aptevo Therapeutics (NASDAQ:APVO)
- Benzinga Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Aurora Cannabis (NASDAQ:ACB), Bitdeer Technologies (NASDAQ:BTDR)
- Benzinga Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket - Acurx Pharmaceuticals (NASDAQ:ACXP), Biomea Fusion (NASDAQ:BMEA)
- Investing U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.70%
- Investing CERo Therapeutics stock soars after FDA grants Orphan Drug Designation
- Benzinga Crude Oil Rises Sharply; Jabil Earnings Top Views - CERo Therapeutics Hldgs (NASDAQ:CERO), Acurx Pharmaceuticals (NASDAQ:ACXP)
- Benzinga US Stocks Lower; Retail Sales Decline In May - CERo Therapeutics Hldgs (NASDAQ:CERO), Acurx Pharmaceuticals (NASDAQ:ACXP)
- Benzinga What's Going On With Cero Therapeutics Stock Tuesday? - CERo Therapeutics Hldgs (NASDAQ:CERO)
- Investing FDA grants orphan drug status to CERo’s leukemia treatment
- Investing U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.79%
- Investing CERo Therapeutics to implement 1-for-20 reverse stock split
- TipRanks Upcoming Stock Splits This Week (June 9 to June 13) – Stay Invested - TipRanks.com
- Investing CERo Therapeutics issues additional Series D stock
- Investing CERo Therapeutics Holdings, Inc. Announces Continued Enhancement of Intellectual Property Portfolio with Two Granted U.S. Patents and European Patent Application Allowance Regarding Company’s Lead
- Investing CERO stock plunges to 52-week low at $0.47 amid market challenges
- Investing CERo Therapeutics begins phase 1 trial for leukemia treatment
- Investing CERO stock plunges to 52-week low of $0.53 amid market challenges
- Investing Maxim Group sets Cero Therapeutics stock with $3 target
- Benzinga Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results - ASGN (NYSE:ASGN), Bristol-Myers Squibb (NYSE:BMY)
- Benzinga Dow Jumps Over 200 Points; PepsiCo Cuts Earnings Outlook - CERo Therapeutics Hldgs (NASDAQ:CERO), Cantor Equity Partners (NASDAQ:CEP)
Rango diario
8.50
8.92
Rango anual
0.04
26.99
- Cierres anteriores
- 8.85
- Open
- 8.85
- Bid
- 8.72
- Ask
- 9.02
- Low
- 8.50
- High
- 8.92
- Volumen
- 205
- Cambio diario
- -1.47%
- Cambio mensual
- -6.34%
- Cambio a 6 meses
- 323.30%
- Cambio anual
- 5350.00%
13 julio, domingo